Effects of oligonucleotide length, mismatches and mRNA levels on C-5 propyne-modified antisense potency

Nucleic Acids Research

Volumn 24, Issue 15, 1996, Pages 2936-2941

  Flanagan, W Michael ^a   Kothavale, Avinash ^a   Wagner, Richard W ^a  

^a GILEAD SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; LUCIFERASE; MESSENGER RNA; TETRACYCLINE;

ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG HALF LIFE; DRUG POTENCY; HELA CELL; HUMAN; HUMAN CELL; NUCLEIC ACID PROBE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TISSUE CULTURE;

DOSE-RESPONSE RELATIONSHIP, DRUG; GENES, REPORTER; HELA CELLS; HUMANS; LUCIFERASES; OLIGODEOXYRIBONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; RNA, MESSENGER; RNA, NEOPLASM; STRUCTURE-ACTIVITY RELATIONSHIP; THIONUCLEOTIDES; TIME FACTORS;

EID: 0030057861     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/24.15.2936     Document Type: Article

References (30)

1. Wagner,R.W., Matteucci,M.D., Lewis,J.G., Gutierrez,A.J., Moulds,C.and Froehler,B.C. (1993) Science, 260, 1510-1513.
2. Wagner,R.W. (1994) Nature, 372, 333-335.
3. Moulds,C., Lewis,J.G., Froehler,B.C., Grant,D., Huang,T., Milligan,J.F., Matteucci,M.D.and Wagner,R.W. (1995) Biochemistry, 34, 5044-53.
4. Wagner,R.W. (1995) Nature Med., 1, 1116-1118.
5. Lewis,J.G., Lin,K.Y., Kothavale,A., Flanagan,W.M., Matteucci,M.D., DePrince,R.B., Mook,R.A., Hendren,R.W.and Wagner,R.W. (1996) Proc. Natl Acad. Sci. USA, 93, 3176-3181.
6. Milligan,J.F., Matteucci,M.D.and Martin,J.C. (1993) J. Med. Chem., 36, 1923-37.
7. Bennett,C.F., Chiang,M.Y., Chan,H., Shoemaker,J.E.and Mirabelli,C.K. (1992) Mol. Pharmacol., 41, 1023-33.
8. Coals,S., Flanagan,W.M., Nourse,J.and Roberts,J.M. (1996) Science, 272, 877-880
9. Glaser,V. (1996) Genet. Engng News, February 1, 1, 16, 17 and 21.
10. Gura,T. (1995) Science, 270, 575-577.
11. Stein,C.A.and Cheng,Y.C. (1993) Science, 261, 1004-12.
12. Stein,C.A. (1995) Nature Med., 1, 1119-1121.
13. Stein,C.A.and Krieg.A.M. (1994) Antisense Res. Dev., 4, 67-9.
14. Krieg,A.M., Yi,A.K., Matson,S., Waldschmidt,T.J., Bishop,G.A., Teasdale,R., Koretzky,G.A.and Klinman,D.M. (1995) Nature, 374, 546-549.
15. Gossen,M.and Bujard,H. (1992) Proc. Natl Acad. Sci. USA, 89, 5547-5551.
16. Froehler,B.C. and Agrawal,S. (eds) (1993) Protocols for Oligonucleotides and Analogs: Synthesis and Properties. Humana Press, Totowa, NJ.
17. Froehler,B.C., Wadwani,S., Terhorst,T.J.and Gerrard,S.R. (1992) Tetrahedron Lett., 33, 5307-5310.
18. Froehler,B.C., Jones,R.J., Cao,X.and Terhorst,T.J. (1993) Tetrahedron Lett., 34, 1003-1006.
19. de Wit,J.R., Wood,K.V., DeLuca,M., Helinski,D.R.and Subramani,S. (1987) Mol. Cell. Biol., 7, 725-737.
20. Fulton,R.and Van Ness,B. (1993) BioTechniaues, 14, 762-3.
21. Ausubel,F.M. et al. (eds) (1989) Current Protocols in Molecular Biology. John Wiley & Sons, New York, NY.
22. Fisher,T.L., Terhorst,T., Cao,X.and Wagner,R.W. (1993) Nucleic Acids Res., 21, 3857-65.
23. Monia,B.P., JohnstonJ.F., Ecker,D.J., Zounes,M.A., Lima,W.F.and Freier,S.M. (1992) J. Biol. Chem., 267, 19954-62.
24. Fenster,S.D., Wagner,R.W., Froehler,B.C.and Chin,D.J. (1994) Biochemistry, 33, 8391-8398.
25. Black,L.E., Degeorge J.J., Cavagnaro,J.A., Jordan,A.and Ahn,C.H. (1993) Antisense Res. Dev., 3, 399-404.
26. Black,L.E., Farrelly,J.G., Cavagnaro,J.A., Ahn,C.-H., DeGeorge,JJ., Taylor,A.S., DeFelice,A.F.and Jordan,A. (1994) Antisense Res. Dev., 4, 299-301.
27. Wagner,R.W., Matteucci,M.D., Grant,D., Huang,T. and Froehler,B.C. (1996) Nature Biotechnol., 14, 838-842.
28. Matteucci,M. (1996) In Trainor,G.L. (ed.), Perspectives in Drug Discovery and Design. ESCOM, Leiden, The Netherlands, Vol. 4, pp. 1-16.
29. De Mesmaeker,A., Haner,R., Martin,P.and Moser,H. (1995) Acc. Chem. Res., 28, 366-374.
30. Rosolen,A., Kyle,E., Chavany,C., Bergan,R., Kalman,E.T., Crouch,R.and Neckers,L. (1993) Biochimie, 75, 79-87.